The updated recommendation expands cervical cancer screening options to include certain FDA-approved self-collection tests.

In early December, the American Cancer Society updated its guidelines for the first time since 2020. Now, all women nationwide are eligible for at-home cervical cancer screening.

The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.